Malaria vaccines

A malaria vaccine is a vaccine that is used to prevent malaria. The only approved vaccine as of 2015 is RTS,S, known by the trade name Mosquirix. It requires four injections, and has a relatively low efficacy. Due to this low efficacy, the World Health Organization (WHO) does not recommend the routine use of the RTS,S vaccine in babies between 6 and 12 weeks of age.A WHO-led implementation program is piloting the vaccine in three high-malaria countries in Africa in 2019. The first phase of the project, covered by grants from Unit aid, Gavi and the Global Fund, is planned to establish the feasibility, impact and safety of RTS, S, when used as part of a routine immunization program. Research continues into recombinant protein, attenuated whole organism and viral vectored vaccines